AQR Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.2M | Buy |
|
|||||
|
2025
Q2 | $11.5M | Buy |
|
|||||
|
2025
Q1 | $804K | Sell |
|
|||||
|
2024
Q4 | $1.56M | Sell |
|
|||||
|
2024
Q3 | $1.97M | Buy |
|
|||||
|
2024
Q2 | $1.81M | Buy |
|
|||||
|
2024
Q1 | $2.12M | Buy |
|
|||||
|
2023
Q4 | $2.31M | Sell |
|
|||||
|
2023
Q3 | $866K | Sell |
|
|||||
|
2023
Q2 | $1.12M | Sell |
|
|||||
|
2023
Q1 | $1.4M | Sell |
|
|||||
|
2022
Q4 | $1.91M | Buy |
|
|||||
|
2022
Q3 | $1.98M | Buy |
|
|||||
|
2022
Q2 | $1.5M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.66M | Buy |
|
|||||
|
2021
Q3 | $362K | Hold |
|
|||||
|
2021
Q2 | $201K | Sell |
|
|||||
|
2021
Q1 | $367K | Sell |
|
|||||
|
2020
Q4 | $340K | Sell |
|
|||||
|
2020
Q3 | $428K | Sell |
|
|||||
|
2020
Q2 | $492K | Sell |
|
|||||
|
2020
Q1 | $255K | Buy |
|
|||||
|
2019
Q4 | $214K | Buy |
|
|||||
|
2019
Q3 | $180K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $126K | Hold |
|
|||||
|
2018
Q1 | $109K | Sell |
|
|||||
|
2017
Q4 | $219K | Buy |
|
|||||
|
2017
Q3 | $371K | Sell |
|
|||||
|
2017
Q2 | $370K | Buy |
|
|||||
|
2017
Q1 | $316K | Buy |
|
|||||
|
2016
Q4 | $236K | Sell |
|
|||||
|
2016
Q3 | $228K | Buy |
|
|||||
|
2016
Q2 | $175K | Hold |
|
|||||
|
2016
Q1 | $130K | Hold |
|
|||||
|
2015
Q4 | $193K | Hold |
|
|||||
|
2015
Q3 | $124K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $87K | Sell |
|
|||||
|
2014
Q1 | $266K | Buy |
|
|||||
|
2013
Q4 | $174K | Hold |
|
|||||
|
2013
Q3 | $203K | Buy |
|